Aetiological diagnosis of ischaemic stroke in young adults

The Lancet Neurology

Volumn 9, Issue 11, 2010, Pages 1085-1096

  Ferro, José M ^a   Massaro, Ayrton R ^b   Mas, Jean Louis ^c  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b UNIVERSITY OF KENTUCKY   (United States)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ANGIOGRAPHY; ARTERY DISEASE; ARTERY DISSECTION; BRAIN ISCHEMIA; CEREBROSPINAL FLUID ANALYSIS; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONNECTIVE TISSUE DISEASE; DEATH; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISABILITY; EMBOLISM; GENETIC ANALYSIS; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; INFECTION; MIGRAINE WITH AURA; NEUROIMAGING; PATENT FORAMEN OVALE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; QUALITY OF LIFE; REVIEW; RISK FACTOR; STROKE; THROMBOPHILIA; VASCULITIS; VISUAL SYSTEM EXAMINATION;

ADULT; AGE FACTORS; BRAIN ISCHEMIA; HUMANS; MIGRAINE DISORDERS; SMOKING; STROKE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77957965123     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70251-9     Document Type: Review

References (111)

1. Correia M, Silva MR, Matos I, et al. Prospective community-based study of stroke in Northern Portugal: incidence and case fatality in rural and urban populations. Stroke 2004, 35:2048-2053.
2. Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009, 40:1195-1203.
3. Baptista MV, Ferreira S, Pinho-E-Melo T, et al. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study-screening genetic conditions in portuguese young stroke patients. Stroke 2010, 41:431-436. on behalf of the PORTYSTROKE Investigators.
4. Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005, 36:1115-1119.
5. Arnold M, Halpern M, Meier N, et al. Age-dependent differences in demographics, risk factors, co-morbidity, etiology, management, and clinical outcome of acute ischemic stroke. J Neurol 2008, 255:1503-1507.
6. Rouanet F, Sibon I, Goizet C, Renou P Bilan étiologique des infarctus cérébraux du sujet jeune. Propositions du groupe de travail de la société française neuro-vasculaire (Décembre 2008). Rev Neurol 2009, 165:F283-F288. Meissner W pour le groupe de travail de la SFNV.
7. Cerrato P, Grasso M, Imperiale D, et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis 2004, 18:154-159.
8. Lipska K, Sylaja PN, Sarma PS, et al. Risk factors for acute ischaemic stroke in young adults in South India. J Neurol Neurosurg Psychiatry 2007, 78:959-963.
9. Mehndiratta MM, Agarwal P, Sen K, Sharma B Stroke in young adults: a study from a university hospital in north India. Med Sci Monit 2004, 10:CR535-CR541.
10. Dharmasaroja PA, Muengtaweepongsa S, Lechawanich C, Pattaraarchachai J Causes of ischemic stroke in young adults in Thailand: a pilot study. J Stroke Cerebrovasc Dis 2010, published online Jun 25. 10.1016/j.jstrokecerebrovasdis.2010.01.004.
11. Samiullah S, Humaira M, Hanif G, Ghouri AA, Shaikh K Etiological patterns of stroke in young patients at a tertiary care hospital. J Pak Med Assoc 2010, 60:201-204.
12. Sundell L, Salomaa V, Vartiainen E, Poikolainen K, Laatikainen T Increased stroke risk is related to a binge-drinking habit. Stroke 2008, 39:3179-3184.
13. Love BB, Biller J, Jones MP, Adams HP, Bruno A Cigarette smoking. A risk factor for cerebral infarction in young adults. Arch Neurol 1990, 47:693-698.
14. Bhat VM, Cole JW, Sorkin JD, et al. Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke 2008, 39:2439-2443.
15. Spengos K, Vemmos K Risk factors, etiology, and outcome of first-ever ischemic stroke in young adults aged 15 to 45-the Athens young stroke registry. Eur J Neurol 2010, published online May 11. 10.1111/j.1468-1331.2010.03065.x.
16. Bi Q, Wang L, Li X, Song Z Risk factors and treatment of stroke in Chinese young adults. Neurol Res 2010, 32:366-370.
17. Isordia-Salas I, Trejo-Aguilar A, Valadés-Mejía MG, et al. C677T polymorphism of the 5,10 MTHFR gene in young Mexican subjects with ST-elevation myocardial infarction. Arch Med Res 2010, 41:246-250.
18. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009, 339:b3914.
19. Bousser MG, Welch KMA Relation between migraine and stroke. Lancet Neurol 2005, 4:533-542.
20. Sharshar T, Lamy C, Mas JL Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995, 26:930-936.
21. Helms AK, Kittner SJ Pregnancy and Stroke. CNS Spectr 2005, 10:580-587.
22. Mas JL, Lamy C Stroke in pregnancy and the puerperium. J Neurol 1998, 245:305-313.
23. Davie CA, O'Brien P Stroke and pregnancy. J Neurol Neurosurg Psychiatry 2008, 79:240-245.
24. Lamy C, Hamon JB, Coste J, Mas JL Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology 2000, 55:269-274.
25. Chakhtoura Z, Canonico M, Gompel A, Thalabard JC, Scarabin PY, Plu-Bureau G Progestogen-only contraceptives and the risk of stroke: a meta-analysis. Stroke 2009, 40:1059-1062.
26. Chan WS, Ray J, Wai EK, et al. Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 2004, 164:741-747.
27. Baillargeon JP, McClish DK, Essah PA, Nestler JE Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005, 90:3863-3870.
28. Etminan M, Takkouche B, Isorna FC, Samii A Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005, 330:63.
29. Curtis KM, Mohllajee AP, Peterson HB Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 2006, 73:189-194.
30. Pruissen DM, Slooter AJ, Rosendaal FR, van der Graaf Y, Algra A Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. Blood 2008, 111:1282-1286.
31. Westover AN, McBride S, Haley RW Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry 2007, 64:495-502.
32. Sloan MA, Kittner SJ, Feeser BR, et al. Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology 1998, 50:1688-1693.
33. Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007, 369:293-298.
34. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997, 205:327-333.
35. Wardlaw JM, Keir SL, Seymour J, et al. What is the best imaging strategy for acute stroke?. Health Technol Assess 2004, 8:1-180.
36. Musolino R, La Spina P, Granata A, et al. Ischaemic stroke in young people: a prospective and long-term follow-up study. Cerebrovasc Dis 2003, 15:121-128.
37. Varona JF, Bermejo F, Guerra JM, Molina JA Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol 2004, 251:1507-1514.
38. Leys D, Bandu L, Hénon H, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 2002, 59:26-33.
39. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
40. Putaala J, Kurkinen M, Tarvos V, Salonen O, Kaste M, Tatlisumak T Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke. Neurology 2009, 72:1823-1829.
41. Wardlaw JM, Chappell FM, Stevenson M, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess 2006, 10:iii-iv. ix-x, 1-182.
42. Wardlaw JM, Chappell FM, Best JJK, Wartolowska K, Berry E Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 2006, 367:1503-1512. on behalf of NHS Research and Development Health Technology Assessment Carotid Stenosis Imaging Group.
43. Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 2004, 35:2306-2312.
44. Khan S, Cloud GC, Kerry S, Markus HS Imaging of vertebral artery stenosis: a systematic review. J Neurol Neurosurg Psychiatry 2007, 78:1218-1225.
45. Nederkoorn PJ, van der Graaf Y, Hunink MG Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke 2003, 34:1324-1332.
46. Douen AG, Pageau N, Medic S Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2·6-fold in patients with acute stroke. Stroke 2008, 39:480-482.
47. Gunalp M, Atalar E, Coskun F, et al. Holter monitoring for 24 hours in patients with thromboembolic stroke and sinus rhythm diagnosed in the emergency department. Adv Ther 2006, 23:854-860.
48. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 2007, 38:2935-2940.
49. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004, 35:1647-1651.
50. Lerakis S, Nicholson WJ Part I: use of echocardiography in the evaluation of patients with suspected cardioembolic stroke. Am J Med Sci 2005, 329:310-316.
51. Kapral MK, Silver FL Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ 1999, 161:989-996.
52. de Bruijn SF, Agema WR, Lammers GJ, et al. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke 2006, 37:2531-2534.
53. Huang TY, Tseng HK, Liu CP, Lee CM Comparison of the clinical manifestations of infective endocarditis between elderly and young patients-a 3-year study. J Microbiol Immunol Infect 2009, 42:154-159.
54. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:676-685.
55. Gegouskov V, Kadner A, Engelberger L, Carrel T, Tevaearai H Papillary fibroelastoma of the heart. Heart Surg Forum 2008, 11:E333-E339.
56. Klötzsch C, Janssen G, Berlit P Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology 1994, 44:1603-1606.
57. Klein IF, Lavallée PC, Mazighi M, Schouman-Claeys E, Labreuche J, Amarenco P Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke 2010, 41:1405-1409.
58. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008, 25:457-507. European Stroke Organisation (ESO) Executive Committee, ESO Writing CommitteeESO Writing Committee.
59. Debette S, Leys D Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 2009, 8:668-678.
60. Arnold M, Pannier B, Chabriat H, et al. Vascular risk factors and morphometric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatry 2009, 80:232-234.
61. Dittrich R, Heidbreder A, Rohsbach D, et al. Connective tissue and vascular phenotype in patients with cervical artery dissection. Neurology 2007, 68:2120-2124.
62. Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S A systematic review of the risk factors for cervical artery dissection. Stroke 2005, 36:1575-1580.
63. Arnold M, De Marchis GM, Stapf C, et al. Triple and quadruple spontaneous cervical artery dissection: presenting characteristics and long-term outcome. J Neurol Neurosurg Psychiatry 2009, 80:171-174.
64. Dittrich R, Nassenstein I, Bachmann R, et al. Polyarterial clustered recurrence of cervical artery dissection seems to be the rule. Neurology 2007, 69:180-186.
65. Nebelsieck J, Sengelhoff C, Nassenstein I, et al. Sensitivity of neurovascular ultrasound for the detection of spontaneous cervical artery dissection. J Clin Neurosci 2009, 16:79-82.
66. Arnold M, Baumgartner RW, Stapf C, et al. Ultrasound diagnosis of spontaneous carotid dissection with isolated Horner syndrome. Stroke 2008, 39:82-86.
67. Vertinsky AT, Schwartz NE, Fischbein NJ, Rosenberg J, Albers GW, Zaharchuk G Comparison of multidetector CT angiography and MR imaging of cervical artery dissection. AJNR Am J Neuroradiol 2008, 29:1753-1760.
68. Touze E, Gauvrit JY, Moulin T, Meder JF, Bracard S, Mas JL Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology 2003, 61:1347-1351.
69. Nedeltchev K, Bickel S, Arnold M, et al. R2-recanalization of spontaneous carotid artery dissection. Stroke 2009, 40:499-504.
70. Cabanes L, Coste J, Derumeaux G, et al. Interobserver and intraobserver variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography. J Am Soc Echocardiogr 2002, 15:441-446. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group.
71. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993, 24:1865-1873.
72. Alsheikh-Ali AA, Thaler DE, Kent DM Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?. Stroke 2009, 40:2349-2355.
73. Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc 2006, 81:602-608.
74. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007, 49:797-802.
75. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 2009, 73:89-97.
76. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001, 345:1740-1746. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group.
77. Castro R, Prieto ES, da Luz Martins Pereira F Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests. J Clin Lab Anal 2008, 22:257-261.
78. Van Snick S, Duprez TP, Kabamba B, Van De Wyngaert FA, Sindic CJ Acute ischaemic pontine stroke revealing lyme neuroborreliosis in a young adult. Acta Neurol Belg 2008, 108:103-106.
79. Topakian R, Stieglbauer K, Nussbaumer K, Aishner FT Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge. Cerebrovasc Dis 2008, 26:455-461.
80. Kalita J, Misra UK, Nair PP Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis 2009, 18:251-258.
81. Lammie GA, Hewlett RH, Schoeman JF, Donald PR Tuberculous cerebrovascular disease: a review. J Infect 2009, 59:156-166.
82. Ries S, Schminke U, Fassbender K, Daffertshofer M, Steinke W, Hennerici M Cerebrovascular involvement in the acute phase of bacterial meningitis. J Neurol 1997, 244:51-55.
83. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009, 8:731-740.
84. Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies. Clinical, CSF, imaging, and virologic features. Neurology 2008, 70:853-860.
85. Dobbs MR, Berger JR Stroke in HIV and AIDS. Expert Rev Cardiovasc Ther 2009, 7:1263-1271.
86. Cantú C, Villareal J, Soto JL, Barinagarrementeria F Cerebral cysticercotic arteritis: detection and follow-up by transcranial doppler. Cerebrovasc Dis 1998, 8:2-7.
87. Carod-Artal FJ Stroke: a neglected complication of American trypanosomiasis (Chagas' disease). Trans R Soc Trop Med Hyg 2007, 101:1075-1080.
88. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009, 8:998-1005.
89. Futrell N, Millikan C Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 1989, 20:583-591.
90. Legierse CM, Canninga-Van Dijk MR, Bruijnzeel-Koomen CA, Kuck-Koot VC Sneddon syndrome and the diagnostic value of skin biopsies-three young patients with intracerebral lesions and livedo racemosa. Eur J Dermatol 2008, 18:322-328.
91. Salvarani C, Brown RD, Calamia KT, Hunder GG, et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007, 62:442-451.
92. Kraemer M, Berlit P Primary central nervous system vasculitis: clinical experiences with 21 new European cases. Rheumatol Int 2009, published online Dec 19. 10.1007/s00296-009-1312-x.
93. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007, 146:34-44.
94. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007, 130:3091-3101.
95. Kuroda S, Houkin K Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008, 7:1056-1066.
96. Kraemer M, Heienbrok W, Berlit P Moyamoya disease in Europeans. Stroke 2008, 39:3193-3200.
97. Rennebohm RM, Egan RA, Susac JO Treatment of Susac's syndrome. Curr Treat Options Neurol 2008, 10:67-74.
98. Switzer JA, Hess DC, Nichols FT, Adams RJ Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006, 5:501-512.
99. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med 1998, 339:5-11.
100. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG CADASIL. Lancet Neurol 2009, 7:643-653.
101. Dong Y, Hassan A, Zhang Z, Huber D, Dalageorgou C, Markus HS Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke 2003, 34:203-205.
102. Adib-Samii P, Brice G, Martin RJ, Markus HS Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 2010, 41:630-634.
103. Linthorst GE, Bouwman MG, Wijburg FA, Aerts JM, Poorthuis BJ, Hollak CE Screening for Fabry disease in high risk populations: a systematic review. J Med Genet 2010, 47:217-222.
104. Rolfs A, Böttcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005, 366:1794-1796.
105. Brouns R, Thijs V, Eyskens F, et al. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke 2010, 41:863-868. BeFaS Investigators.
106. Sims K, Politei J, Banikazemi M, Lee P Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 2009, 40:788-794.
107. Alamowitch S, Plaisier E, Favrole P, Prost C, Chen Z, Van Agtmael T, Marro B, Ronco P Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome. Neurology 2009, 73:1873-1882.
108. Amarenco P Underlying pathology of stroke of unknown cause (cryptogenic stroke). Cerebrovasc Dis 2009, 27(Suppl 1):97-103.
109. Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS). Int J Stroke 2007, 2:292-296. Cervical Artery Dissection in Stroke Study Trial Investigators.
110. Engelter ST, Brandt T, Debette S, et al. Antiplatelets versus anticoagulation in cervical artery dissection. Stroke 2007, 38:2605-2611. for the Cervical Artery Dissection in Ischemic Stroke Patients (CADISP) Study Group.
111. Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008, 39:2644-2691. American Heart Association Stroke Council, Council on Cardiovascular Disease in the YoungCouncil on Cardiovascular Disease in the Young.